Marex Group plc

Position in HIMS — Hims & Hers Health, Inc.

CIK 1997464 London, X0

Position in HIMS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$27,793,778

-$50,767,970 QoQ

Shares Held

1,338,814

-44.7% QoQ

Ownership

0.578%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Marex Group plc holds $32,136,552 across 11 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (86.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HIMS	Hims & Hers Health, Inc. This page	1,338,814	$27,793,778
2	RGC	Regencell Bioscience Holdings Ltd	31,600	$803,588
3	ALKS	Alkermes plc.	19,891	$703,345
4	TEVA	Teva Pharmaceutical Industries Ltd	22,529	$678,573
5	NBIX	Neurocrine Biosciences Inc	4,920	$648,160
6	INDV	Indivior Pharmaceuticals, Inc.	13,413	$408,827
7	BHC	Bausch Health Companies Inc.	74,772	$403,768
8	VTRS	Viatris Inc	25,594	$345,774

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,793,778	1,338,814	-44.7%	Shares	Defined	2026-05-13
2025-12-31	$78,561,748	2,419,518	+162.2%	Shares	Defined	2026-02-12
2025-09-30	$52,341,839	922,811	-14.7%	Shares	Defined	2025-11-14
2025-06-30	$53,911,578	1,081,476	+233.0%	Shares	Defined	2025-08-19
2025-03-31	$9,596,451	324,753	+2542.8%	Shares	Defined	2026-04-02
2024-12-31	$297,123	12,288	-88.4%	Shares	Defined	2026-04-02
2024-09-30	$1,950,806	105,907	+0.9%	Shares	Defined	2026-04-07
2024-06-30	$2,119,950	105,000	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.